跳至主要内容
临床试验/TCTR20151021001
TCTR20151021001已完成4 期

Demineralized Bone Matrix (DBM) Add-On for Acceleration of Bone Healing in Atypical Subtrochanteric Femoral Fracture: A Consecutive Case-Control Study

Faculty of Medicine Ramathibodi Hospital, Mahidol University0 个研究点目标入组 18 人开始时间: 2015年10月21日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
55 Years 至 100 Years(—)
性别
All

入选标准

  • 1) newly diagnosed as AFFs regarding to the criteria of ASBMR Task Force 2013, 2) having the fracture located on the subtrochanter defined as the area of 5 centimeters below to the lesser trochanter, 3) aged over 55 years, and 4) no history of previous allergy to DBM

排除标准

  • 1) other pathological fragility fractures such as fractures from metastasis or primary tumor or simple osteoporotic fractures apart from AFFs, 2) history of high-energy trauma such as motorcycle accident, and 3) fracture location distal to 5-cm below lesser trochanter

研究者

相似试验

Demineralized Bone Matrix (DBM) Add-On for... | 临床试验